Market revenue in 2024 | USD 103.1 million |
Market revenue in 2030 | USD 107.7 million |
Growth rate | 0.7% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.25% in 2024. Horizon Databook has segmented the Mexico hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico's HAI diagnostics market features global players such as BD (Becton, Dickinson and Company), Roche Diagnostics, and Siemens Healthineers, along with regional firms such as Laboratorios Pisa. Global firms dominate with advanced diagnostic technologies, while local companies provide costeffective solutions.
Recent acquisitions, such as BD's integration of new molecular testing platforms, highlight market consolidation. Strategies to gain competitive advantage include collaborations with hospitals and government healthcare programs to enhance access and affordability. Increasing investment in automation and digital health integration further distinguishes leading players.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account